Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of Current and New Biomarkers in Severe Preeclampsia: A Microarray Approach Reveals the VSIG4 Gene as a Potential Blood Biomarker

9 Dec 2013

Abstract excerpt

Preeclampsia is a placental disease characterized by hypertension and proteinuria in pregnant women, and it is associated with a high maternal and neonatal morbidity. However, circulating biomarkers that are able to predict the prognosis of preeclampsia are lacking. Thirty-eight women were included in the current study. They consisted of 19 patients with preeclampsia (13 with severe preeclampsia and 6 with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Birth, Development, and Health
Share to Pregnancy and preeclampsia studies
Share to Reproductive System and Pregnancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24349325
DOI: 10.1371/journal.pone.0082638

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of Current and New Biomarkers in Severe Preeclampsia: A Microarray Approach Reveals the VSIG4 Gene as a Potential Blood BiomarkerPMID 24349325Read ↗

Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.Semantic proximity Read ↗

Characterizing immune variation and diagnostic indicators of preeclampsia by single-cell RNA sequencing and machine learningSemantic proximity Read ↗

Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: The intersection of clinical, pathological, and high-dimensional biology studiesSemantic proximity Read ↗

Comprehensive microarray analysis of severe preeclampsia placenta to identify differentially expressed genes, biological pathways, hub genes, and their related non-coding RNAsSemantic proximity Read ↗

Analysis of the Placental Tissue Transcriptome of Normal and Preeclampsia Complicated PregnanciesSemantic proximity Read ↗

Gene expression profiling of maternal blood in early onset severe preeclampsia: identification of novel biomarkersSemantic proximity Read ↗

Integration of Single-Cell Sequencing and Transcriptomic Analysis to Identify Novel Diagnostic Biomarkers for Preeclampsia and Explore Changes in Immune Cell InteractionsSemantic proximity Read ↗

A Review of Candidate Genes and Pathways in Preeclampsia–An Integrated Bioinformatical AnalysisSemantic proximity Read ↗

Human placental bed transcriptomic profiling reveals inflammatory activation of endothelial cells in preeclampsiaSemantic proximity Read ↗

Microarray Screening for Novel Preeclampsia Biomarker CandidatesSemantic proximity Read ↗

Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomicsSemantic proximity Read ↗

Circulating microRNAs are elevated in plasma from severe preeclamptic pregnanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.